Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.
Press releases published on October 19, 2025
Pulitzer-Prize Nominated Authors to Host Veterans Day Tribute in Bozeman MT
Community Event Will Feature Real Stories of Courage and Healing BOZEMAN, MT, UNITED STATES, October 19, 2025 /EINPresswire.com/ -- To honor the service and sacrifice of America's military heroes, acclaimed authors Dino Garner and Liz Fetter will host a …
Saudi Arabia’s KFSHRC Ranks Among the World’s Top Centers for Kidney Transplant Outcomes
RIYADH, SAUDI ARABIA, October 19, 2025 /EINPresswire.com/ -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has recorded exceptional kidney transplant survival rates, with one-year patient and graft survival ranging between 97 percent and …
Ryoncil® Net Revenues Increase 69% in Second Quarter Post Launch
NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the first quarter ended September 30, …
NETRIS Pharma to Present Clinical Results of NP137 in Combination with Immune Checkpoint Inhibitors at ESMO 2025
Primary efficacy endpoint met in secondary refractory patients LYON, FRANCE, October 19, 2025 /EINPresswire.com/ -- NETRIS Pharma, a clinical-stage biotechnology company pioneering novel therapies targeting Netrin-1 to overcome resistance to …
KISS Medtec and Om Surgical Form Strategic Partnership to Accelerate MedTech Innovation
William Peavey joins Om Surgical as CEO as the companies unite proven implant systems with next-gen marketing and growth execution across the U.S. SAN JOSE, CA, CA, UNITED STATES, October 18, 2025 /EINPresswire.com/ -- San Jose, CA — October 17, 2025 — …
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress
Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease control rate of 91% No maximum tolerated dose reached …
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced data from a new ad hoc analysis from the IGNYTE …
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …